Diabetic Retinopathy
515
45
64
279
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Published Results
55 trials with published results (11%)
Research Maturity
279 completed trials (54% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.2%
32 terminated out of 515 trials
89.7%
+3.2% vs benchmark
16%
81 trials in Phase 3/4
20%
55 of 279 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 279 completed trials
Clinical Trials (515)
A Multicenter, Randomized Study in Participants With Diabetic Retinopathy Without Center-involved Diabetic Macular Edema To Evaluate the Efficacy, Safety, and Pharmacokinetics of Ranibizumab Delivered Via the Port Delivery System Relative to the Comparator Arm
National Eye Institute Biorepository for Retinal Diseases
Study of the SCD411 Prefilled Syringe for Treating Adults With Wet Age-Related Macular Degeneration, Retinal Vein Occlusion, Diabetic Macular Edema, or Diabetic Retinopathy
The Hong Kong Diabetes Biobank
Patient Navigator Intervention for Diabetic Retinopathy
Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes Patients
AI-Assisted Detection of Posterior Segment Diseases: DR, AMD, RVO, and Glaucoma
Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease
Levodopa for Diabetic Retinopathy
Analysis of DR Progression to Identify Risks and Need for Treatment
OPTDR01 Feasibility for Automated Diabetic Retinopathy Detection
Serum Endocan, Alarin, and Galanin-Like Peptide Levels in Diabetic Retinopathy
Prevention of Onset and Transition to an Advanced Form of Diabetic Retinopathy in Children
Retinal Ischemia Characterization in Diabetes - "RICHARD"
Implementation of Teleophthalmology in Urban Health Systems Study
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
Early Percutaneous Transluminal Angioplasty in Diabetic Foot Syndrome (PTA-DFS)
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy
Study of INV-102 Ophthalmic Solution in Adults With Diabetic Macular Edema Associated With Non-proliferative Diabetic Retinopathy